[1]JAIRATH V, REHAL S, LOGAN R, et al.Acute variceal haemorrhage in the United Kingdom:Patient characteristics, management and outcomes in a nationwide audit[J].Dig Liver Dis, 2014, 46 (5) :419-426.
|
[2]SVOBODA P, KONECNY M, MARTINEK A, et al.Acute upper gastrointestinal bleeding in liver cirrhosis patients[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2012, 156 (3) :266-270.
|
[3]KUJOVICH JL.Coagulopathy in liver diseas:A balancing act[J].Hematology Am Soc Hematol Educ Program, 2015, 2015 (1) :243-249.
|
[4]LI J, QI X, DENG H, et al.Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointestinal bleeding in liver cirrhosis:A retrospective study[J].Gastroenterol Rep (Oxf) , 2016, 4 (4) :315-319.
|
[5]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
|
[6]CHAWLA YK, KASHINATH RC, DUSEJA A, et al.Predicting mortality across a broad spectrum of liver disease:An assessment of model for end-stage liver disease (meld) , child-turcotte-pugh (CTP) , and creatinine-modified ctp scores[J].J Clin Exp Hepatol, 2011, 1 (1) :161-168.
|
[7]TRIPODI A.The coagulopathy of chronic liver disease:Is there a causal relationship with bleeding?NO[J].Eur J Intern Med, 2010, 21 (2) :65-69.
|
[8]BASILI S, RAPARELLI V, VIOLI F.The coagulopathy of chronic liver disease:Is there a causal relationship with bleeding?Yes[J].Eur J Intern Med, 2010, 21 (2) :62-64.
|
[9]JAMIL Z, MALIK M, DURRANI AA.Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis[J].Turk J Gastroenterol, 2017, 28 (5) :347-352.
|
[10]PENG Y, QI X, DAI J, et al.Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis[J].Int J Clin Exp Med, 2015, 8 (1) :751-757.
|
[11]ZOCCO MA, di STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.
|
[12]LISMAN T, PORTE RJ.Rebalanced hemostasis in patients with liver disease:evidence and clinical consequences[J].Blood, 2010, 116 (6) :878-885.
|
[13]TRIPODI A, MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med, 2011, 365 (2) :147-156.
|
[14]LEE JH, KWEON OJ, LEE MK, et al.Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease[J].Int J Hematol, 2015, 102 (2) :163-169.
|
[15]TRIPODI A, PRIMIGNANI M, LEMMA L, et al.Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method[J].Hepatology, 2010, 52 (1) :249-255.
|
[16]FENG L, SUN K, ZHANG J, et al.A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection:A retrospective cohort study[J].BMJOpen, 2015, 5 (9) :e008032.
|
[17]TRIPODI A, PRIMIGNANI M, CHANTARANGKUL V, et al.An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis[J].Gastroenterology, 2009, 137 (6) :2105-2111.
|
[18]TROTTER JF, BRIMHALL B, ARJAL R, et al.Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation[J].Liver Transpl, 2004, 10 (8) :995-1000.
|
[19]TRIPODI A, SALERNO F, CHANTARANGKUL V, et al.Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests[J].Hepatology, 2005, 41 (3) :553-558.
|
[20]LIAO WC, HOU MC, CHANG CJ, et al.Potential precipitating factors of esophageal variceal bleeding:A case-control study[J].Am J Gastroenterol, 2011, 106 (1) :96-103.
|
[21]GIANNINI EG, GRECO A, MARENCO S, et al.Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease[J].Clin Gastroenterol Hepatol, 2010, 8 (10) :899-902.
|
[22]HONG WD, DONG LM, JIANG ZC, et al.Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis[J].Clinics (Sao Paulo) , 2011, 66 (1) :119-124.
|
[23]MADHOTRA R, MULCAHY HE, WILLNER I, et al.Prediction of esophageal varices in patients with cirrhosis[J].J Clin Gastroenterol, 2002, 34 (1) :81-85.
|
[24]ZAMAN A, BECKER T, LAPIDUS J, et al.Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage[J].Arch Intern Med, 2001, 161 (21) :2564-2570.
|
[25]LALOSEVIC MS, STOJKOVIC M, NAUMOVIC T, et al.Clinical scores for the prediction of esophageal varices in patients with liver cirrhosis[J].Acta Gastroenterol Belg, 2016, 79 (1) :14-17.
|
[26]SHARARA AI, ROCKEY DC.Gastroesophageal variceal hemorrhage[J].N Engl J Med, 2001, 345 (9) :669-681.
|
[27]QI X, CHEN H, HAN G.Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis:A meta-analysis[J].Am J Med Sci, 2013, 346 (1) :38-44.
|
[28]TISCHENDORF M, MIESBACH W, CHATTAH U, et al.Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis:Potential clinical implications[J].PLo S One, 2016, 11 (5) :1-9.
|
[29]TRIPODI A, CALDWELL SH, HOFFMAN M, et al.Review article:The prothrombin time test as a measure of bleeding risk and prognosis in liver disease[J].Aliment Pharmacol Ther, 2007, 26 (2) :141-148.
|
[30]SEGAL J, DZIK W.Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures:An evidence-based review[J].Transfusion, 2005, 45 (9) :1413-1425.
|
[31]TACKE F, FIEDLER K, von DEPKA M, et al.Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease[J].Liver Int, 2006, 26 (2) :173-181.
|
[32]GARBUZENKO DV.Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding[J].Curr Med Res Opin, 2016, 32 (3) :467-475.
|
[33]BENDTSEN F, D'AMICO G, RUSCH E, et al.Effect of recombinant factor VIIa on outcome of acute variceal bleeding:an individual patient based meta-analysis of two controlled trials[J].J Hepatol, 2014, 61 (2) :252-259.
|
[34]BOSCH J, THABUT D, ALBILLOS A, et al.Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis:A randomized, controlled trial[J].Hepatology, 2008, 47 (5) :1604-1614.
|